CXCR3 chemokine receptor ligands in sarcoidosis

CXCR3 chemokine receptor ligands in sarcoidosis

Sarcoidosis is a polysystemic inflammatory disease of unknown etiology, morphologically related to the group of granulomatosis, with heterogeneous clinical manifestations and outcomes. Immune cells, in particular T helper cells, are attracted to lung tissue and/or other organs by chemokine gradients...

Full description

Bibliographic Details
Main Authors:	N. M. Lazareva, O. P. Baranova, I. V. Kudryavtsev, N. A. Arsentieva, N. E. Liubimova, T. P. Ses’, M. M. Ilkovich, Areg A. Totolian
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2021-03-01
Series:	Медицинская иммунология
Subjects:	sarcoidosis chemokines cxcl9 cxcl10 cxcl11 cxcr3 ligands peripheral blood plasma
Online Access:	https://www.mimmun.ru/mimmun/article/view/2181

Similar Items

The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
by: Nathan Reynders, et al.
Published: (2019-06-01)

Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01)

Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo
by: Giovanny Aguilera-Durán, et al.
Published: (2020-09-01)

The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis
by: Karolina A. Zielińska, et al.
Published: (2020-10-01)

Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases
by: Zijian Pan, et al.
Published: (2022-03-01)

CXCR2 Is Deregulated in ALS Spinal Cord and Its Activation Triggers Apoptosis in Motor Neuron-Like Cells Overexpressing hSOD1-G93A
by: Valentina La Cognata, et al.
Published: (2023-07-01)

Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL 11 in basal cell carcinoma
by: Mariya K Ansari, et al.
Published: (2023-01-01)

The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy
by: Nicholas S. Giacobbi, et al.
Published: (2024-02-01)

CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors
by: Jingjing Yu, et al.
Published: (2023-06-01)

Tumor-Associated Microglia/Macrophages as a Predictor for Survival in Glioblastoma and Temozolomide-Induced Changes in CXCR2 Signaling with New Resistance Overcoming Strategy by Combination Therapy
by: Ruth M. Urbantat, et al.
Published: (2021-10-01)

CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
by: Xinxin Huang, et al.
Published: (2022-02-01)

Interleukin-8 in Melanoma Pathogenesis, Prognosis and Therapy—An Integrated View into Other Neoplasms and Chemokine Networks
by: Anca Filimon, et al.
Published: (2021-12-01)

Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?
by: Nathan Karin
Published: (2021-12-01)

The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer
by: Raquel Bodoque-Villar, et al.
Published: (2023-09-01)

IRF5 inhibits prostate cancer metastasis and drug resistance by decreasing CXCR4/CXCL12 complex
by: Ozge Cevik, et al.
Published: (2021-12-01)

CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer
by: Jan Korbecki, et al.
Published: (2022-02-01)

CHEMOKINES CCL17 AND CCL22 IN SARCOIDOSIS
by: N. M. Lazareva, et al.
Published: (2021-10-01)

Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line
by: Ari Matsumoto, et al.
Published: (2023-04-01)

Pathophysiological role of chemokine MIG/CXCL9 in the development of atopic dermatitis
by: I. V. Kibalina, et al.
Published: (2022-05-01)

Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients
by: Crescenzo D’Alterio, et al.
Published: (2022-04-01)

The Importance of CXCL1 in Physiology and Noncancerous Diseases of Bone, Bone Marrow, Muscle and the Nervous System
by: Jan Korbecki, et al.
Published: (2022-04-01)

The Potential Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Cardiovascular System, Respiratory System and Skin
by: Jan Korbecki, et al.
Published: (2022-12-01)

Features of cytokine profile in patients with sarcoidosis
by: N. M. Lazareva, et al.
Published: (2020-12-01)

A meta-analysis of chemokines in vitiligo: Recruiting immune cells towards melanocytes
by: Reinhart Speeckaert, et al.
Published: (2023-02-01)

CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma
by: Ju-Fang Liu, et al.
Published: (2020-08-01)

Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells
by: Maria Neves, et al.
Published: (2022-10-01)

CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
by: Tripti Khare, et al.
Published: (2021-07-01)

CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
by: Seong-Kyu Kim, et al.
Published: (2023-02-01)

Identification of potential biomarkers of gout through weighted gene correlation network analysis
by: Xinyi Wang, et al.
Published: (2024-04-01)

The effect of transplantation of cultured autologous melanocytes on CXCL9, CXCL10 and CXCL11 expressions in vitiligo
by: Chen Xu, et al.
Published: (2023-01-01)

Catecholamines Promote Ovarian Cancer Progression through Secretion of CXC-Chemokines
by: Hyun Jung Kim, et al.
Published: (2023-09-01)

Assessment of Immune and Clinical Response in Patients with Mucosal Leishmaniasis Treated with Pentavalent Antimony and Pentoxifylline
by: Carolina Cincura, et al.
Published: (2022-11-01)

CXCL1/CXCR2 Paracrine Axis Contributes to Lung Metastasis in Osteosarcoma
by: Chia-Chia Chao, et al.
Published: (2020-02-01)

Behavior of Chemokine Receptor 6 (CXCR6) in Complex with CXCL16 Soluble form Chemokine by Molecular Dynamic Simulations: General Protein‒Ligand Interaction Model and 3D-QSAR Studies of Synthetic Antagonists
by: Giovanny Aguilera-Durán, et al.
Published: (2021-04-01)

CXCL1-CXCR2 signalling mediates hypertensive retinopathy by inducing macrophage infiltration
by: Shuai Wang, et al.
Published: (2022-10-01)

The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs
by: Jan Korbecki, et al.
Published: (2022-06-01)

ROLE OF CXCR3 CHEMOKINE RECEPTOR AND ITS LIGANDS IN CERTAIN DISEASES
by: N. A. Arsentieva, et al.
Published: (2019-10-01)

The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
by: Tzu-Yi Chia, et al.
Published: (2024-01-01)

Testosterone Inhibits Secretion of the Pro-Inflammatory Chemokine CXCL1 from Astrocytes
by: Malgorzata Turniak-Kusy, et al.
Published: (2024-03-01)

CXCL10 Chemokine: A Critical Player in RNA and DNA Viral Infections
by: Noha Mousaad Elemam, et al.
Published: (2022-11-01)